Osaka, Japan

Akira Kugimiya

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 90(Granted Patents)


Location History:

  • Kyoto, JP (2012)
  • Osaka, JP (2004 - 2021)
  • Toyonaka, JP (2016 - 2023)

Company Filing History:


Years Active: 2004-2023

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Akira Kugimiya: Innovator in Nucleic Acid Medicine

Introduction: Akira Kugimiya is a notable inventor based in Osaka, Japan, recognized for his significant contributions to the field of nucleic acid medicine. With a remarkable portfolio that includes 16 patents, Kugimiya has dedicated his career to advancing therapeutic technologies aimed at improving gene expression regulation.

Latest Patents: Two of his latest patents underscore his innovative approach to enhancing nucleic acid therapeutics. The first is a complex of nucleic acid medicine and multibranched lipid. The primary goal of this invention is to provide novel complexes that improve the efficacy of nucleic acid medicines. It introduces a complex in which multibranched lipids bind through a linker to an oligonucleotide strand, featuring nucleic acid medicines designed to suppress target gene expression effectively. The second patent is for a MicroRNA-143 derivative, which aims to offer novel miR-143 derivatives that can serve as oligonucleotide therapeutics, broadening the application of RNA-based treatments.

Career Highlights: Throughout his career, Akira Kugimiya has worked with several prestigious organizations, including Shionogi & Company Limited and Baylor College of Medicine. These affiliations have allowed him to collaborate on cutting-edge research, furthering the frontiers of medical science.

Collaborations: Kugimiya's work has included collaborations with notable colleagues, such as Yuki Tachibana and Yasunori Mitsuoka. These partnerships emphasize the importance of teamwork in driving innovation and the development of new medical therapies.

Conclusion: Akira Kugimiya exemplifies the spirit of innovation within the realm of biotechnology and nucleic acid medicine. His extensive patent portfolio reflects his commitment to enhancing therapeutic methods that hold the potential to transform patient care and treatment outcomes. His continued work will undoubtedly lead to further breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…